Status:

COMPLETED

Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.

Lead Sponsor:

Hospital Universitario Central de Asturias

Collaborating Sponsors:

Hospitales Universitarios Virgen del Rocío

Conditions:

Stroke, Acute

Infarction, Middle Cerebral Artery

Eligibility:

All Genders

18-80 years

Phase:

PHASE1

PHASE2

Brief Summary

The aim of the study is to determine the safety and efficacy on an autologous CD34+ subset bone marrow stem cell infusion into the middle cerebral artery in patients who have suffered acute middle cer...

Detailed Description

The proposed trial will involve the recruitment of a total of 20 patients. The cells will be collected from ten subject recruited as cases, via bone marrow sampling. The aspirate will be centrifuged ...

Eligibility Criteria

Inclusion

  • Symptoms and signs of clinically definite middle cerebral artery acute stroke.
  • Time of stroke onset is known and treatment can be started between day 5 and 9 of onset.
  • DWI-MRI has reliably shown relevant acute ischemic lesions
  • Extracranial duplex/transcranial Doppler must confirm intra/extracranial arteries permeability.
  • The stroke is severe (NIH Stroke Scale \>= 8 before procedure).
  • An age range of 18-80 years old.

Exclusion

  • Patients out of inclusion age range.
  • Lacunar infarction.
  • Patients with cancer.
  • Patients with present or previous malignant disease during the last 5 years, except for basal cell carcinoma.
  • Hematological causes of stroke.
  • Severe co-morbidity.
  • Hepatic or renal dysfunction.
  • The patient is female and of childbearing potential (unless it is certain that pregnancy is not possible) or breast feeding.
  • Patient is likely to be unavailable for follow-up.
  • Patient with evidence of life threatening infection of life threatening illness.
  • Patient was already dependent in activities of daily living before the present acute stroke.

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2011

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00761982

Start Date

September 1 2008

End Date

August 1 2011

Last Update

November 29 2011

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospitales Universitarios Virgen del Rocío

Seville, Andalusia, Spain

2

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, Spain, 33006